| Market Access Manager |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Market Access |
11. November 2024 |
| Sr. Sales Executive-BC |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
10. November 2024 |
| (Sr.) Sales Executive-Solid Tumor |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
04. November 2024 |
| Key Account Executive |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
28. Oktober 2024 |
| Key Account Executive |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
28. Oktober 2024 |
| Key Account Executive |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
28. Oktober 2024 |
| Key Account Executive |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
28. Oktober 2024 |
| Key Account Executive |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
28. Oktober 2024 |
| Key Account Executive |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
28. Oktober 2024 |
| Key Account Executive |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
28. Oktober 2024 |
| Key Account Executive |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
28. Oktober 2024 |
| Key Account Executive |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
28. Oktober 2024 |
| Key Account Executive |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
28. Oktober 2024 |
| Key Account Executive |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
28. Oktober 2024 |
| (Senior) Medical Advisor (Radioligand Therapy) |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Research & Development |
09. Oktober 2024 |
| Associate Sales Manager |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
18. Juli 2024 |
| (Sr.) Sales Executive-OPH |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
12. Juni 2024 |